Telix Pharmaceuticals enters into Exclusive Licence Agreement with Osaka University
Telix announces an exclusive Intellectual Property (IP) licence with Osaka University for a novel radiochemistry...
Read moreLatest News
Category: ASX
Telix Quarterly Shareholder Update – CEO Presentation and Transcript of Investor Conference Call
Telix Pharmaceuticals is pleased to provide its Quarterly Shareholder Update presentation and the transcript of CEO Dr Chris Behrenbruch’s conference call with...
Read more
Activity Report and Sales Note to Accompany Appendix 4C
Telix provides its Appendix 4C for the quarter ending 31st March 2020 and a Q1 2020 sales update for its prostate cancer imaging...
Read more
AGM Notice of Meeting – Telix Pharmaceuticals Limited
Telix Pharmaceuticals provides notice of The Annual General Meeting of the Shareholders on Tuesday 12 May...
Read more
Telix Pharmaceuticals Enters Commercial Distribution Agreement for Prostate Cancer Diagnostic
Telix Pharmaceuticals (U.S.) Inc. is pleased to announce it has entered into a commercial agreement with Cardinal...
Read more
Telix Completes Acquisition of European Radiopharmaceutical Production Facility
Telix is pleased to announce it has now completed the acquisition of a licensed radiopharmaceutical production facility in Seneffe,...
Read more
Telix Pharmaceuticals and partners receive $500K research grant from Government funded Innovative Manufacturing CRC
Telix and partners receive $500K research grant from Government-funded Innovative Manufacturing CRC to advance manufacturing of novel cancer...
Read more
Positive FDA Feedback on NDA Submission Process for TLX591-CDx (kit for the preparation of 68Ga-PSMA-11)
Telix Pharmaceuticals announces that it has received positive feedback from the FDA regarding its submission of an NDA for...
Read more
Telix Pharmaceuticals Releases Annual Report Year Ending 2019
Telix Pharmaceuticals Limited Releases Annual Report Year Ending...
Read more
Telix Pharmaceuticals and ATONCO Partner for Bladder Cancer
Telix Pharmaceuticals Limited and French company ATONCO S.A.S are pleased to announce they have entered into a Licence and Development Agreement that will enable ATONCO to investigate the use of Telix’s...
Read more